SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-014907
Filing Date
2019-10-03
Accepted
2019-10-02 17:47:26
Documents
15
Period of Report
2019-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 38950
2 ex10-1.htm EX-10.1 6080
3 ex10-1_001.jpg GRAPHIC 214470
4 ex10-1_002.jpg GRAPHIC 242080
5 ex10-1_003.jpg GRAPHIC 43144
6 ex10-1_004.jpg GRAPHIC 51660
7 ex10-1_005.jpg GRAPHIC 64263
8 ex10-2.htm EX-10.2 6080
9 ex10-2_001.jpg GRAPHIC 212941
10 ex10-2_002.jpg GRAPHIC 241602
11 ex10-2_003.jpg GRAPHIC 43155
12 ex10-2_004.jpg GRAPHIC 50628
13 ex10-2_005.jpg GRAPHIC 64258
14 ex10-3.htm EX-10.3 1424
15 ex10-3_001.jpg GRAPHIC 173083
  Complete submission text file 0001493152-19-014907.txt   1985058
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184948 | Film No.: 191133386
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences